Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive

Rigas G Kalaitzidis1, Thalia Panagiotopoulou2, Dimitrios Stagikas2

  • 1Hypertension Excellence Centre, Division of Nephrology, University Hospital of Ioannina, Ioannina, Greece.

Insights

Improving blood pressure control in hypertension involves addressing patient adherence. Stable antihypertensive drug combinations enhance adherence, which is crucial for managing arterial stiffness and cognitive function.

Area of Science:

  • Cardiovascular Medicine
  • Neuroscience
  • Pharmacology

Background:

  • Hypertension (HTN) and its cardiovascular (CV) complications are globally increasing, with unsatisfactory blood pressure (BP) control rates.
  • Medical inertia and poor treatment adherence significantly contribute to low BP control rates.
  • Arterial stiffness, induced by HTN, elevates CV and stroke risk and is linked to cognitive dysfunction.

Purpose of the Study:

  • To review the interrelationships between arterial stiffness, cognitive function, and medication adherence in patients with hypertension.
  • To explore how arterial stiffness impacts cognitive function and, consequently, treatment adherence.
  • To highlight the benefits of addressing arterial stiffness for cognitive health and adherence.

Main Methods:

  • Literature review focusing on studies examining hypertension, arterial stiffness, cognitive function, and medication adherence.
  • Analysis of the mechanisms linking HTN, arterial stiffness, and cognitive impairment.
  • Evaluation of the impact of adherence on BP control and arterial stiffness.

Main Results:

  • Hypertension can induce arterial stiffness, which is associated with increased CV and stroke risk.
  • HTN-induced arterial stiffness can lead to brain microcirculation disorders and cognitive dysfunction, particularly memory deficits.
  • Cognitive dysfunction negatively impacts adherence to antihypertensive drug treatment.
  • Compliance with antihypertensive therapy improves BP control and arterial stiffness indices.

Conclusions:

  • Stable combinations of antihypertensive drugs improve patient adherence compared to complex regimens.
  • Early intervention for arterial stiffness is recommended to enhance cognitive function and improve medication adherence.
  • Addressing arterial stiffness is a key strategy for improving overall management of hypertension and its complications.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
587
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.9K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
452
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
480
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
603
Cognitive Dissonance01:38

Cognitive Dissonance

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
36.8K